CIK 0001178253
- Non-accelerated filer
- Smaller reporting company
SCYNEXIS INC
Sign in to watch- Ticker
- SCYX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 562181648
- Phone
- +1 201-884-5485
- Business address
- 1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 76 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-15 | Sukenick Scott General Counsel | Grant or award | +100,000 | 102,959 | ||
| 2019-02-15 | Sukenick Scott General Counsel | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2019-02-15 | Francois Eric Chief Financial Officer | Grant or award | +125,000 | 149,917 | ||
| 2019-02-15 | Francois Eric Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2019-02-15 | Angulo Gonzalez David Chief Medical Officer | Grant or award | +150,000 | 271,790 | ||
| 2019-02-15 | Angulo Gonzalez David Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2019-01-21 | ANIDO ARMANDO Director | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2019-01-10 | Taglietti Marco Chief Executive Officer | Purchase | +25,000 | $0.69 | $17K | 480,000 |
| 2019-01-02 | Machado Patrick Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2019-01-02 | Macdonald Guy Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2019-01-02 | HASTINGS DAVID C Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2019-01-02 | HANHAM ANN Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2019-01-02 | GILMAN STEVEN C Director | Grant or award · Stock Option (right to buy) | +22,500 | 22,500 | ||
| 2018-12-31 | Taglietti Marco Chief Executive Officer | Purchase | +25,000 | $0.46 | $12K | 455,000 |
| 2018-12-31 | Angulo Gonzalez David Chief Medical Officer | Purchase | +12,000 | $0.50 | $6K | 121,790 |
| 2018-10-01 | Macdonald Guy Director | Grant or award · Stock option (right to buy) | +21,595 | $0.79 | $17K | 21,595 |
| 2018-09-06 | Angulo Gonzalez David Chief Medical Officer | Purchase | +7,000 | $1.27 | $9K | 108,790 |
| 2018-08-23 | Taglietti Marco Chief Executive Officer | Purchase | +25,000 | $1.29 | $32K | 429,000 |
| 2018-07-02 | McCourt Marion Director | Grant or award · Stock option (right to buy) | +9,217 | $1.10 | $10K | 9,217 |
| 2018-07-02 | Macdonald Guy Director | Grant or award · Stock option (right to buy) | +15,589 | $1.10 | $17K | 15,589 |
Page 10 of 15 · 286 trades